The difference in expression was observed not only in the two genes ACTB and GAPDH, which are most frequently used as normalizers in RCC studies, but also in the gene HPRT1. The latter was recently recommended as single reference gene for gene expression studies in cancer research [44]. This evidence concerns the gene GAPDH and renal cell carcinoma.